New Jersey’s Lung Transplant Program Earns Medicare Approval

NEWARK—The final step in making lung transplant an available treatment option for all New Jersey residents was accomplished this week when the state’s only Lung Transplant Program at Newark Beth Israel Medical Center received approval from the U.S. Department of Health and Human Services’ Centers for Medicare and Medicaid Services (CMS).

To meet the growing demand for lung transplants in NJ, Newark Beth Israel Medical Center has expanded its multidisciplinary clinical team and welcomes Sinan A. Simsir, MD, Surgical Director of the Lung Transplant Program.


The Lung Transplant Program at Newark Beth Israel has been active since the spring of 2008 following the necessary approvals from the New Jersey Department of Health and Senior Services and the United Network for Organ Sharing. Newark Beth Israel’s lung transplant team has already performed 12 life-saving transplants successfully.

The additional approval by CMS is significant because it opens access to lung transplant for New Jersey residents who are eligible for Medicare.

“Until now, many people with severe chronic lung disease faced the added burden of traveling to a neighboring state to seek care at a CMS-approved hospital,” said Sean Studer, MD, MSc, Director of the Lung Transplant Program at Newark Beth Israel. “That posed a significant barrier to what may be their most appropriate treatment option.”

Strict criteria for CMS approval of an organ transplant program includes full review of the center’s policies and procedures, coordination of care, outcomes, and volume of transplants performed at the center. Newark Beth Israel Medical Center joins 54 other CMS-approved lung transplant programs nationwide. The Lung Transplant Program also accepts almost all private insurance payors.

While the standard of care at approved centers is uniform, the wait time for an organ transplant can vary greatly from center to center. For example, the median wait time in 2008 for a lung transplant in New Jersey was 1.9 months compared to 30.5 months at New York Presbyterian Hospital-Columbia University Medical Center and 15.5 months at the Hospital of the University of Pennsylvania in Philadelphia.

“The positive effects of an in-state program are twofold,” said Dr. Studer. “Our work with the NJ Sharing Network is helping to increase organ donation across the state and the lungs that are donated in New Jersey are matched, whenever possible, to transplant candidates in New Jersey. These factors combine to create the shortest wait time in the region for a lung transplant,” he explained.

New Jersey residents who are currently on lung transplant waiting lists in New York and/or Pennsylvania can also be listed at the Lung Transplant Program at Newark Beth Israel. Each of the regions is served by a different organ procurement organization, therefore multiple listings at various centers is permitted by the United Network of Organ Sharing, which administers all of the nation’s organ procurement, matching and placement activities.

To learn more about the Lung Transplant Program at Newark Beth Israel Medical Center, please call 1-800-NJ-Lung1 or log on to .

Connect with NJTODAY.NET

Join NJTODAY.NET's free Email List to receive occasional updates delivered right to your email address!
Email for advertising information Send stuff to NJTODAY.NET Like Us On Facebook Follow Us On Twitter Download this week's issue of NJTODAY.NET
Print Friendly, PDF & Email